European Healthtech startup funding raised during August 2021.
In August 2021, 51 European Healthtech companies raised a combined €706M across 51 funding rounds, up 75.2% versus August 2020. UK led by capital raised, and Adage Capital Management was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Pepgen | Other | Aug 2021 | €95M |
| T-knife | Series B | Aug 2021 | €93M |
| Beckley Psytech | Series B | Aug 2021 | €68M |
| Cardior Pharmaceuticals | Series B |
| Acquisition |
| Aug 2021 |
| €171M |
| Phasya | Acquisition | Aug 2021 | €4.0M |
| Aug 2021 |
| €64M |
| DnaNudge | Series A | Aug 2021 | €51M |
| Tissium | Series C | Aug 2021 | €50M |
| Anocca | Series B | Aug 2021 | €40M |
| Ottonova | Other | Aug 2021 | €40M |
| BrainQ | Other | Aug 2021 | €34M |
| Ultromics | Series B | Aug 2021 | €28M |
| EpiEndo Pharmaceuticals | Series A | Aug 2021 | €20M |
| SolasCure | Series A | Aug 2021 | €18M |
| Eyevensys | Series B | Aug 2021 | €10M |
| Hagar | Series B | Aug 2021 | €10.0M |
| BiVictriX | Other | Aug 2021 | €8.8M |
